Ghana’s COVID-19 case management team has begun an engagement to decide the use of hydroxychloroquine as COVID-19 treatment after the World Health Organisation ordered its suspension.
This was revealed by the Director-General of the Ghana Health Service, Dr. Patrick Aboagye at a press briefing to update Ghanaians on government’s COVID-19 situation and fight.
WHO has suspended the use of hydroxychloroquine due to concerns about the safety and health implications of the drug.
The move comes after a recent medical study suggested the drug could increase the risk of patients dying from COVID-19.
But speaking at a press briefing, Dr. Aboahye said they haven’t received formal communication from WHO yet but the country’s case management team is in a meeting to decide on what to do.
He noted that Ghana only uses the hydroxychloroquine for critical cases and not routine cases. Currently, 15 people have severe conditions but not on ventilators.
However, he assured that the decision taken after the meeting would be communicated.
Dr. Aboagye said “As I speak now, we wait for the formal communication but the case management team now are meeting to take a decision on what to do. We only use it for critical cases, we don’t use it for routine cases. Those who are being managed at home do not take hydroxychloroquine. So the case management team as we speak are in a meeting to quickly take a decision on what we will do. And when we do it will be adequately communicated.”
Ghana’s COVID-19 cases have increased to 6,964 with 2,097 recoveries and 32 deaths.